Fidson Healthcare Plc has announced plans to conduct a Bioequivalence study on the production of chewable formulation of Albendazole tablets in partnership with Liddie BE Limited, a leading clinical research organisation. Albendazole tablet is a worm medication approved by the United States Food and Drug Administration for the treatment of a variety of parasitic worm
